Total Assets
Stockholders' Equity
Cash & Equivalents
Long-Term Debt
Revenue trend
Balance Sheet
Income Statement
Per Share & Cash Flow
Insider activity
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Aug 29, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its FY2026 report, Eton Pharmaceuticals, Inc. reported total assets of $115.8M, stockholders' equity of $46.6M, and revenue of $37.6M. Every figure below is taken directly from Eton Pharmaceuticals, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue · FY2019–FY2025 · as reported
as of Jun 30, 2026 · 10-Q
10-Q (quarterly) · period ended Jun 30, 2026
| Revenue | $37.6M | Revenue | source ↗ |
| Net Income | $11.6M | Net | source ↗ |
| Operating Income | $12.8M | Operating | source ↗ |
| Gross Profit | $25.4M | Gross | source ↗ |
| Cost of Revenue | $12.2M | Cost | source ↗ |
| R&D Expense | $993,000 | Research | source ↗ |
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $0.35 | Earnings | source ↗ |
| EPS (basic) | $0.42 | Earnings | source ↗ |
| Shares Outstanding | 28.6M | Entity | source ↗ |
| Cash from Operations | $7.3M | Net | source ↗ |
| Cash from Financing | -$76,000 | Net | source ↗ |
| Cash from Investing | $5,000 | Net | source ↗ |
Form 4 open-market activity, last 180 days
4 of 236 annual fact-keys were materially restated between filings: what Eton Pharmaceuticals, Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail behind the counts above, plus MCP access for your own agents, across the whole SEC universe.
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.